Estetrol Approvals Mark 'Turning Point' For Mithra

Also Plans Further Launches Of Myring Generic Rival To NuvaRing

 
• By David Wallace
Turning Point Sign
Recent developments for Estelle mark a “turning point” for Mithra • Source: Alamy

More from Strategy

More from Business